MMP-9 polymorphisms are related to serum lipids levels but not associated with colorectal cancer susceptibility in Chinese population

Molecular Biology Reports

Volumn 39, Issue 10, 2012, Pages 9399-9404

  Yang, Zhi Hui ^a   Li, Shi Ning ^a   Liu, Jin Xing ^a   Guo, Qing Xi ^a   Sun, Xing Wang ^a  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Genetic polymorphisms; MMP 9; Serum lipids

Indexed keywords

CHOLESTEROL; GELATINASE B; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHEMOLUMINESCENCE; CHINESE; CHOLESTEROL BLOOD LEVEL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MATRIX METALLOPROTEINASE 9 GENE; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT;

ADULT; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, LDL; COLORECTAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MUTATION, MISSENSE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; TUMOR MARKERS, BIOLOGICAL;

EID: 84868563363     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1804-8     Document Type: Article

References (31)

1. Werb Z (1997) ECM and cell surface proteolysis: regulating cellular ecology. Cell 91:439-442
2. Curran S, Murray GI (1999) Matrix metalloproteinases in tumor invasion and metastasis. J Pathol 189:300-308
3. Stamenkovic I (2000) Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 10:415-433
4. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174
5. Liu SC, Yang SF, Yeh KT et al (2006) Relationships between the level of matrix metalloproteinase-2 and tumor size of breast cancer. Clin Chim Acta 371:92-96
6. Islekel H, Oktay G, Terzi C et al (2007) Matrix metalloproteinase-9, -3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables. Cell Biochem Funct 25:433-441
7. Shellman YG, Makela M, Norris DA (2006) Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines. Melanoma Res 16:207-211
8. Zheng H, Takahashi H, Murai Y et al (2006) Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 6:3579-3583
9. Ye S (2000) Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 19:623-629
10. Wilson CL, Matrisian LM (1996) Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 28:123-136
11. Cox G, Jones JL, O'Byrne KJ (2000) Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable nonsmall cell lung cancer. Clin Cancer Res 6:2349-2355
12. Jordan RC, Macabeo-Ong M, Shiboski CH et al (2004) Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer. Clin Cancer Res 10:6460-6465
13. Aglund K, Rauvala M, Puistola U et al (2004) Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage. Gynecol Oncol 94:699-704
14. Zhao W, Liu H, Xu S et al (2001) Migration and metalloproteinases determine the invasive potential of mouse melanoma cells, but not melanin and telomerase. Cancer Lett 162 Suppl: S49-S55
15. Hu Z, Huo X, Lu D et al (2005) Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer. Clin Cancer Res 11:5433-5439
16. Wu J, Zhang L, Luo H et al (2008) Association of matrix metalloproteinases-9 gene polymorphisms with genetic susceptibility to esophageal squamous cell carcinoma. DNA Cell Biol 27:553-557
17. Tang Y, Zhu J, Chen L et al (2008) Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer. Clin Cancer Res 14:2870-2877
18. Beeghly-Fadiel A, Lu W, Shu XO et al (2011) MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study. Breast Cancer Res Treat 126:507-513
19. Gil Ugarteburu R, Rivas del Fresno M, González Rodríguez I et al (2010) Matrix metalloproteinase-9 polymorphisms in the diagnosis of prostate cancer. A preliminary experience. Arch Esp Urol 63:125-132
20. Srivastava P, Mandhani A, Kapoor R et al (2010) Role of MMP-3 and MMP-9 and their haplotypes in risk of bladder cancer in North Indian cohort. Ann Surg Oncol 17:3068-3075
21. Dragutinović VV, Radonjić NV, Petronijević ND et al (2011) Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer. Mol Cell Biochem 355:173-178
22. Chu D, Zhao Z, Zhou Y et al (2012) Matrix metalloproteinase-9 is associated with relapse and prognosis of patients with colorectal cancer. Ann Surg Oncol 19(1):318-325
23. Opstad TB, Pettersen AA, Weiss TW et al (2012) Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease. Clin Chim Acta 413:113-120
24. Ghaderian SM, Akbarzadeh Najar R, Tabatabaei Panah AS (2010) Genetic polymorphisms and plasma levels of matrix metalloproteinases and their relationships with developing acute myocardial infarction. Coron Artery Dis 21:330-335
25. Vairaktaris E, Vassiliou S, Nkenke E et al (2008) A metalloproteinase-9 polymorphism which affects its expression. Eur J Surg Oncol 34:450-455
26. Chawda JG, Jain SS, Patel HR et al (2011) The relationship between serum lipid levels and the risk of oral cancer. Indian J Med Paediatr Oncol 32:34-37
27. Owiredu WK, Donkor S, Addai BW et al (2009) Serum lipid profile of breast cancer patients. Pak J Biol Sci 12:332-338
28. Tomiki Y, Suda S, Tanaka M et al (2004) Reduced low-densitylipoprotein cholesterol causing low serum cholesterol levels in gastrointestinal cancer: a case control study. J Exp Clin Cancer Res 23:233-240
29. Motta M, Giugno I, Ruello P et al (2001) Lipoprotein (a) behaviour in patients with hepatocellular carcinoma. Minerva Med 92:301-305
30. Tao LJ, Qin YQ (2002) Alteration of serum lipids in patients with acute leukemia and its clinical significance. Zhongguo Shi Yan Xue Ye Xue Za Zhi 10:371-372
31. Saedi M, Vaisi-Raygani A, Khaghani S et al (2012) Matrix metalloproteinase-9 functional promoter polymorphism 1562 C>T increased risk of early-onset coronary artery disease. Mol Biol Rep 39:555-562